Improved Survival in Patients with First Relapsed or Refractory Acute Myeloid Leukemia (AML) Treated with Vosaroxin Plus Cytarabine Versus Placebo Plus Cytarabine: Results of a Phase 3 Double-Blind Randomized Controlled Multinational Study (VALOR)


Conference Paper

Full Text

Duke Authors

Cited Authors

  • Ravandi, F; Ritchie, E; Sayar, H; Lancet, J; Craig, MD; Vey, N; Strickland, SA; Schiller, G; Jabbour, E; Erba, HP; Pigneux, A; Horst, H-A; Recher, C; Klimek, VM; Cortes, J; Feldman, EJ; Craig, AR; Fox, JA; Ward, R; Smith, J; Acton, G; Mehta, C; Kantarjian, HM; Stuart, RK

Published Date

  • December 6, 2014

Published In

Volume / Issue

  • 124 / 21

Published By


  • 4

Electronic International Standard Serial Number (EISSN)

  • 1528-0020

International Standard Serial Number (ISSN)

  • 0006-4971

Conference Name

  • 56th Annual Meeting of the American-Society-of-Hematology

Conference Location

  • San Francisco, CA

Conference Start Date

  • December 6, 2014

Conference End Date

  • December 9, 2014